Back to top
more

QuidelOrtho (QDEL)

(Delayed Data from NSDQ)

$41.05 USD

41.05
902,643

-0.92 (-2.19%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $41.04 -0.01 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (73 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

What's in the Cards for Quidel (QDEL) This Earnings Season?

Quidel (QDEL) is expected to have gained from its Molecular Diagnostic Solutions business in Q1.

Ritujay Ghosh headshot

Trump Pushes for US-Made Medical Products: 4 Winners

An executive order to address the lack of medical product manufacturing in the United States could in a way boost manufacturing and sales of home-grown goods.

Quidel (QDEL) Earnings Expected to Grow: Should You Buy?

Quidel (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Quidel (QDEL) is an Incredible Growth Stock: 3 Reasons Why

Quidel (QDEL) is well positioned to outperform the market, as it exhibits above-average growth in financials.

The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics

The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics

Coronavirus Test Kit Demand to Drive These 3 Stocks

Point-of-care testing enables better patient triage, bed management, and patient care decisions. Here are three stocks to benefit as demand rises.

Quidel (QDEL) Looks Good: Stock Adds 10.8% in Session

Quidel (QDEL) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.

Earnings Preview: Quidel (QDEL) Q4 Earnings Expected to Decline

Quidel (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Quidel (QDEL) Surpasses Q3 Earnings and Revenue Estimates

Quidel (QDEL) delivered earnings and revenue surprises of 7.69% and 0.69%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Quidel (QDEL) Reports Next Week: Wall Street Expects Earnings Growth

Quidel (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Quidel (QDEL) Q2 Earnings Meet Estimates

Quidel (QDEL) delivered earnings and revenue surprises of 0.00% and 0.26%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Quidel (QDEL) Reports Next Week: Wall Street Expects Earnings Growth

Quidel (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Trina Mukherjee headshot

Medical Products Industry Outlook: Growth Prospects Radiant

Growth prospects look bright for the Zacks Medical Products industry, thanks to AI, Medical Mechatronics and Robotics and rampant M&As.

QDEL vs. BAX: Which Stock Is the Better Value Option?

QDEL vs. BAX: Which Stock Is the Better Value Option?

Masimo's O3 Oximetry Gets FDA Nod, Boosts Patient Monitoring

Masimo (MASI) gets FDA nod for its O3 Regional Oximetry that will help in delivering accurate measurement with respect to neonatal patients.

Zacks.com featured highlights include: lululemon, Quidel, China Yuchai and Logitech

Zacks.com featured highlights include: lululemon, Quidel, China Yuchai and Logitech

Ecolab Unveils Innovative Tested Tool to Improve Food Safety

Ecolab's (ECL) innovative tested tool aims to improve food safety and ensure customer safety.

Here's Why You Should Invest in Integer Holdings (ITGR) Stock

Integer Holdings (ITGR) continues to benefit from portfolio management, strong foothold in the broader MedTech space and rising Non-Medical sales.

Here's Why You Should Retain HMS Holdings (HMSY) Stock

HMS Holdings (HMSY) is gaining traction from the growing PI and TPM analytical services. However, stiff competition remains a concern.

Tirthankar Chakraborty headshot

4 Top Efficient Stocks to Boost Your Portfolio

A company with a favorable efficiency level is expected to provide stellar returns as it is believed to be positively correlated with price performance.

Here's Why You Should Retain NextGen Healthcare (NXGN) Stock

NextGen Healthcare (NXGN) is gaining traction from the U.S. RCM market and the growing EHR market. However, margin pressure remains a concern.

Here's Why You Should Invest in DexCom (DXCM) Stock Now

DexCom (DXCM) is gaining traction from lucrative glucose monitoring market, solid international market presence and strong product portfolio.

Here's Why You Should Hold on to Medidata (MDSO) Stock Now

Medidata Solutions (MDSO) continues to benefit from solid R&D focus, Rave Genomics platform and cloud-based services. However, stiff competition remains a concern.

Here's Why You Should Bet on Merit Medical (MMSI) Stock Now

Merit Medical (MMSI) continues to benefit from solid product pipeline, HeRO product line and persistent focus on R&D.